Company Overview of Urigen Pharmaceuticals, Inc.
Urigen Pharmaceuticals, Inc., a development stage company, engages in the development and commercialization of therapeutic products for patients with urological disorders in North America. Its clinical stage product includes URG101, a bladder instillation for bladder pain syndrome/intersticial cystitis for men and women. The company is based in Wilmington, Delaware.
501 Silverside Road
Wilmington, DE 19809
Key Executives for Urigen Pharmaceuticals, Inc.
Urigen Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Triax Pharmaceuticals, LLC||United States|
|Coley Pharmaceutical Group, Inc.||United States|
|The Tylenol Company||United States|
|VisionQuest Worldwide Holdings Corp.||United States|
|ThyoGen Pharmaceuticals Inc.||United States|
Recent Private Companies Transactions
May 27, 2014
To contact Urigen Pharmaceuticals, Inc., please visit www.urigen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.